Acupuncture vs. herbal injections: which eases chronic neck pain better?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients with neck pain persisting for more than 3 months 2. Patients with a Numeric Rating Scale (NRS) score of 5 or higher for neck pain 3. Patients aged between 19 and 70 years 4. Patients who agree to participate in the clinical study and provide a written informed consent form Exclusion Criteria: 1. Patients diagnosed with serious specific diseases that could be the cause of neck pain (e.g., spinal metastasis of tumors, acute fractures, and spinal dislocations) 2. Patients exhibiting progressive neurological deficits or severe neurological symptoms 3. Patients whose pain originates from soft tissue disorders rather than the spine (e.g., tumors, fibromyalgia, rheumatoid arthritis, gout) 4. Patients with other chronic diseases that could interfere with the interpretation of treatment effects or outcomes (e.g., stroke, myocardial infarction, kidney disease, diabetic neuropathy, dementia, epilepsy) 5. Patients currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that could affect the study results 6. Patients for whom pharmacopuncture treatment is inappropriate or unsafe: those with bleeding disorders, those undergoing anticoagulant therapy, and severe diabetic patients with infection risks 7. Patients who have taken medications that could affect pain (e.g., Non-Steroidal Anti-Inflammatory Drugs, NSAIDs) or received pharmacopuncture, acupuncture, or physical therapy within the past week 8. Pregnant women, those planning to become pregnant, or those currently breastfeeding 9. Patients who have undergone cervical spine surgery within the past 3 months 10. Patients who have not completed participation in another clinical study within the past month or plan to participate in another clinical study during the study participation and follow-up period within 6 months from the date of selection 11. Patients who find it difficult to provide informed consent for participation 12. Other cases where the researcher deems participation in the clinical study to be difficult